LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Profit Margin

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) currently reports a profit margin of -66.9% as of March 2024. That compares with 12.79% in the prior-year period — down 623.2% year over year. That is below the sector sector average of 13.78%. Use the charts on this page to explore LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s profit margin history and peer comparisons.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s profit margin decreased from 12.79% to -66.9% — a 623.2% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s profit margin of -66.9% is lower than the its sector sector average of 13.78%. That is roughly 585.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s current -66.9% should be judged against industry norms (sector average: 13.78%) and against LSBPW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -66.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.78%. From there, open related valuation or income-statement pages for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028), and consider following LSBPW for alerts when major investors trade the stock.